Loading…

Dioxin Affects Glucose Transport via the Arylhydrocarbon Receptor Signal Cascade in Pluripotent Embryonic Carcinoma Cells

Intoxication by dioxins such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) leads, among other damages, to early embryo loss, fetal malformations, and cardiovascular toxicity. Apart from binding to the arylhydrocarbon receptor (AhR), the mechanism of TCDD-mediated embryo toxicity is still unclear. We...

Full description

Saved in:
Bibliographic Details
Published in:Endocrinology (Philadelphia) 2007-12, Vol.148 (12), p.5902-5912
Main Authors: Tonack, Sarah, Kind, Karen, Thompson, Jeremy G, Wobus, Anna M, Fischer, Bernd, Santos, Anne Navarrete
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c558t-3dfc8f8c8ba4bed87132b043de118588a9b5b97a1d501f0042c1e12eed9fad683
cites cdi_FETCH-LOGICAL-c558t-3dfc8f8c8ba4bed87132b043de118588a9b5b97a1d501f0042c1e12eed9fad683
container_end_page 5912
container_issue 12
container_start_page 5902
container_title Endocrinology (Philadelphia)
container_volume 148
creator Tonack, Sarah
Kind, Karen
Thompson, Jeremy G
Wobus, Anna M
Fischer, Bernd
Santos, Anne Navarrete
description Intoxication by dioxins such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) leads, among other damages, to early embryo loss, fetal malformations, and cardiovascular toxicity. Apart from binding to the arylhydrocarbon receptor (AhR), the mechanism of TCDD-mediated embryo toxicity is still unclear. We investigated possible modes of a TCDD-mediated toxicity, particularly in glucose metabolism, in pluripotent P19 mouse embryonic carcinoma cells. Undifferentiated P19 cells were exposed to 1–100 nm TCDD and characterized for AhR signaling. For studying cell differentiation, P19 cells were exposed to 10 nm TCDD at stage of embryoid body formation, and analyzed on glucose metabolism and cardiac differentiation during the next 3 wk. TCDD treatment activated the AhR-signaling cascade within 1 h, confirmed by AhR translocation, induction of cytochrome P450 1A1 expression, and activation of the xenobiotic response element. Although cell viability and transcription of the cardiac marker protein α-myosin heavy chain were affected, TCDD did not inhibit the differentiation of P19 cells to pulsating cardiomyocytes. TCDD significantly down-regulated the expression levels of the glucose transporter (GLUT) isoforms 1 and 3. After 24-h TCDD treatment, GLUT1 was no longer localized in the plasma membrane of P19 cells. The impaired GLUT expression correlated with a lower glucose uptake in 5-d-old embryoid bodies. The TCDD effects were mediated by AhR, as shown by preculture with the AhR antagonist α-naphthoflavone. Our data demonstrate that an AhR-mediated disturbance in GLUT expression and insufficient glucose uptake may be major mechanisms in TCDD embryo toxicity.
doi_str_mv 10.1210/en.2007-0254
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19896613</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1210/en.2007-0254</oup_id><sourcerecordid>19896613</sourcerecordid><originalsourceid>FETCH-LOGICAL-c558t-3dfc8f8c8ba4bed87132b043de118588a9b5b97a1d501f0042c1e12eed9fad683</originalsourceid><addsrcrecordid>eNp10VFr1TAUB_AgDnc3ffNZAuJ8WWdO0zbp4-U6N2Gg6HwuaXLqMtqkJq2s395cbuGCKARC4Mc5OedPyGtgV5AD-4DuKmdMZCwvi2dkA3VRZgIEe042jAHPRJ6LU3IW42N6FkXBX5BTEFLkXBQbsny0_sk6uu061FOkN_2sfUR6H5SLow8T_W0VnR6QbsPSPywmeK1C6x39hhrHyQf63f50qqc7FbUySFOxr_0c7OgndBO9HtqweGd1AkFb5wdFd9j38SU56VQf8dV6n5Mfn67vd7fZ3Zebz7vtXabLUk4ZN52WndSyVUWLRgrgecsKbhBAllKqui3bWigwJYOOsSLXgJAjmrpTppL8nFwc6o7B_5oxTs1go04_UA79HBuoZV1VwBN8-xd89HNIo8WGA2elLEXFkro8KB18jAG7Zgx2UGFpgDX7QBp0zT6QZh9I4m_WonM7oDniNYEE3q1gv7--S3vXNh5dLStIJ7n3B-fn8X8ts7UlP0h0xutgHY4BYzxO88-P_gGRN7E8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3130585760</pqid></control><display><type>article</type><title>Dioxin Affects Glucose Transport via the Arylhydrocarbon Receptor Signal Cascade in Pluripotent Embryonic Carcinoma Cells</title><source>Oxford Journals Online</source><creator>Tonack, Sarah ; Kind, Karen ; Thompson, Jeremy G ; Wobus, Anna M ; Fischer, Bernd ; Santos, Anne Navarrete</creator><creatorcontrib>Tonack, Sarah ; Kind, Karen ; Thompson, Jeremy G ; Wobus, Anna M ; Fischer, Bernd ; Santos, Anne Navarrete</creatorcontrib><description>Intoxication by dioxins such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) leads, among other damages, to early embryo loss, fetal malformations, and cardiovascular toxicity. Apart from binding to the arylhydrocarbon receptor (AhR), the mechanism of TCDD-mediated embryo toxicity is still unclear. We investigated possible modes of a TCDD-mediated toxicity, particularly in glucose metabolism, in pluripotent P19 mouse embryonic carcinoma cells. Undifferentiated P19 cells were exposed to 1–100 nm TCDD and characterized for AhR signaling. For studying cell differentiation, P19 cells were exposed to 10 nm TCDD at stage of embryoid body formation, and analyzed on glucose metabolism and cardiac differentiation during the next 3 wk. TCDD treatment activated the AhR-signaling cascade within 1 h, confirmed by AhR translocation, induction of cytochrome P450 1A1 expression, and activation of the xenobiotic response element. Although cell viability and transcription of the cardiac marker protein α-myosin heavy chain were affected, TCDD did not inhibit the differentiation of P19 cells to pulsating cardiomyocytes. TCDD significantly down-regulated the expression levels of the glucose transporter (GLUT) isoforms 1 and 3. After 24-h TCDD treatment, GLUT1 was no longer localized in the plasma membrane of P19 cells. The impaired GLUT expression correlated with a lower glucose uptake in 5-d-old embryoid bodies. The TCDD effects were mediated by AhR, as shown by preculture with the AhR antagonist α-naphthoflavone. Our data demonstrate that an AhR-mediated disturbance in GLUT expression and insufficient glucose uptake may be major mechanisms in TCDD embryo toxicity.</description><identifier>ISSN: 0013-7227</identifier><identifier>EISSN: 1945-7170</identifier><identifier>DOI: 10.1210/en.2007-0254</identifier><identifier>PMID: 17872374</identifier><identifier>CODEN: ENDOAO</identifier><language>eng</language><publisher>Bethesda, MD: Endocrine Society</publisher><subject>Animals ; Benzoflavones - pharmacology ; Biological and medical sciences ; Biological Transport - drug effects ; Blotting, Western ; Cardiomyocytes ; Cell activation ; Cell differentiation ; Cell Differentiation - drug effects ; Cell Line, Tumor ; Cell Survival - drug effects ; Cell viability ; Cytochrome P-450 CYP1A1 - genetics ; Cytochrome P-450 CYP1A1 - metabolism ; Cytochrome P450 ; Cytochromes P450 ; Differentiation (biology) ; Dioxins ; Dioxins - pharmacology ; Embryos ; Fetuses ; Fundamental and applied biological sciences. Psychology ; Gene Expression - drug effects ; Glucose ; Glucose - metabolism ; Glucose transport ; Glucose transporter ; Glucose Transporter Type 1 - genetics ; Glucose Transporter Type 1 - metabolism ; Glucose Transporter Type 3 - genetics ; Glucose Transporter Type 3 - metabolism ; Heart ; Intoxication ; Isoforms ; Metabolism ; Mice ; Myocytes, Cardiac - cytology ; Myocytes, Cardiac - drug effects ; Myocytes, Cardiac - metabolism ; Myosin ; Naphthoflavone ; Pluripotency ; Polychlorinated Dibenzodioxins - pharmacology ; Receptors ; Receptors, Aryl Hydrocarbon - antagonists &amp; inhibitors ; Receptors, Aryl Hydrocarbon - physiology ; Reverse Transcriptase Polymerase Chain Reaction ; Signal Transduction - drug effects ; TCDD ; Toxicity ; Transcription activation ; Transcription, Genetic ; Translocation ; Vertebrates: endocrinology</subject><ispartof>Endocrinology (Philadelphia), 2007-12, Vol.148 (12), p.5902-5912</ispartof><rights>Copyright © 2007 by The Endocrine Society 2007</rights><rights>2008 INIST-CNRS</rights><rights>Copyright © 2007 by The Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c558t-3dfc8f8c8ba4bed87132b043de118588a9b5b97a1d501f0042c1e12eed9fad683</citedby><cites>FETCH-LOGICAL-c558t-3dfc8f8c8ba4bed87132b043de118588a9b5b97a1d501f0042c1e12eed9fad683</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19861861$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17872374$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tonack, Sarah</creatorcontrib><creatorcontrib>Kind, Karen</creatorcontrib><creatorcontrib>Thompson, Jeremy G</creatorcontrib><creatorcontrib>Wobus, Anna M</creatorcontrib><creatorcontrib>Fischer, Bernd</creatorcontrib><creatorcontrib>Santos, Anne Navarrete</creatorcontrib><title>Dioxin Affects Glucose Transport via the Arylhydrocarbon Receptor Signal Cascade in Pluripotent Embryonic Carcinoma Cells</title><title>Endocrinology (Philadelphia)</title><addtitle>Endocrinology</addtitle><description>Intoxication by dioxins such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) leads, among other damages, to early embryo loss, fetal malformations, and cardiovascular toxicity. Apart from binding to the arylhydrocarbon receptor (AhR), the mechanism of TCDD-mediated embryo toxicity is still unclear. We investigated possible modes of a TCDD-mediated toxicity, particularly in glucose metabolism, in pluripotent P19 mouse embryonic carcinoma cells. Undifferentiated P19 cells were exposed to 1–100 nm TCDD and characterized for AhR signaling. For studying cell differentiation, P19 cells were exposed to 10 nm TCDD at stage of embryoid body formation, and analyzed on glucose metabolism and cardiac differentiation during the next 3 wk. TCDD treatment activated the AhR-signaling cascade within 1 h, confirmed by AhR translocation, induction of cytochrome P450 1A1 expression, and activation of the xenobiotic response element. Although cell viability and transcription of the cardiac marker protein α-myosin heavy chain were affected, TCDD did not inhibit the differentiation of P19 cells to pulsating cardiomyocytes. TCDD significantly down-regulated the expression levels of the glucose transporter (GLUT) isoforms 1 and 3. After 24-h TCDD treatment, GLUT1 was no longer localized in the plasma membrane of P19 cells. The impaired GLUT expression correlated with a lower glucose uptake in 5-d-old embryoid bodies. The TCDD effects were mediated by AhR, as shown by preculture with the AhR antagonist α-naphthoflavone. Our data demonstrate that an AhR-mediated disturbance in GLUT expression and insufficient glucose uptake may be major mechanisms in TCDD embryo toxicity.</description><subject>Animals</subject><subject>Benzoflavones - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Biological Transport - drug effects</subject><subject>Blotting, Western</subject><subject>Cardiomyocytes</subject><subject>Cell activation</subject><subject>Cell differentiation</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell Line, Tumor</subject><subject>Cell Survival - drug effects</subject><subject>Cell viability</subject><subject>Cytochrome P-450 CYP1A1 - genetics</subject><subject>Cytochrome P-450 CYP1A1 - metabolism</subject><subject>Cytochrome P450</subject><subject>Cytochromes P450</subject><subject>Differentiation (biology)</subject><subject>Dioxins</subject><subject>Dioxins - pharmacology</subject><subject>Embryos</subject><subject>Fetuses</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression - drug effects</subject><subject>Glucose</subject><subject>Glucose - metabolism</subject><subject>Glucose transport</subject><subject>Glucose transporter</subject><subject>Glucose Transporter Type 1 - genetics</subject><subject>Glucose Transporter Type 1 - metabolism</subject><subject>Glucose Transporter Type 3 - genetics</subject><subject>Glucose Transporter Type 3 - metabolism</subject><subject>Heart</subject><subject>Intoxication</subject><subject>Isoforms</subject><subject>Metabolism</subject><subject>Mice</subject><subject>Myocytes, Cardiac - cytology</subject><subject>Myocytes, Cardiac - drug effects</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Myosin</subject><subject>Naphthoflavone</subject><subject>Pluripotency</subject><subject>Polychlorinated Dibenzodioxins - pharmacology</subject><subject>Receptors</subject><subject>Receptors, Aryl Hydrocarbon - antagonists &amp; inhibitors</subject><subject>Receptors, Aryl Hydrocarbon - physiology</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Signal Transduction - drug effects</subject><subject>TCDD</subject><subject>Toxicity</subject><subject>Transcription activation</subject><subject>Transcription, Genetic</subject><subject>Translocation</subject><subject>Vertebrates: endocrinology</subject><issn>0013-7227</issn><issn>1945-7170</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNp10VFr1TAUB_AgDnc3ffNZAuJ8WWdO0zbp4-U6N2Gg6HwuaXLqMtqkJq2s395cbuGCKARC4Mc5OedPyGtgV5AD-4DuKmdMZCwvi2dkA3VRZgIEe042jAHPRJ6LU3IW42N6FkXBX5BTEFLkXBQbsny0_sk6uu061FOkN_2sfUR6H5SLow8T_W0VnR6QbsPSPywmeK1C6x39hhrHyQf63f50qqc7FbUySFOxr_0c7OgndBO9HtqweGd1AkFb5wdFd9j38SU56VQf8dV6n5Mfn67vd7fZ3Zebz7vtXabLUk4ZN52WndSyVUWLRgrgecsKbhBAllKqui3bWigwJYOOsSLXgJAjmrpTppL8nFwc6o7B_5oxTs1go04_UA79HBuoZV1VwBN8-xd89HNIo8WGA2elLEXFkro8KB18jAG7Zgx2UGFpgDX7QBp0zT6QZh9I4m_WonM7oDniNYEE3q1gv7--S3vXNh5dLStIJ7n3B-fn8X8ts7UlP0h0xutgHY4BYzxO88-P_gGRN7E8</recordid><startdate>20071201</startdate><enddate>20071201</enddate><creator>Tonack, Sarah</creator><creator>Kind, Karen</creator><creator>Thompson, Jeremy G</creator><creator>Wobus, Anna M</creator><creator>Fischer, Bernd</creator><creator>Santos, Anne Navarrete</creator><general>Endocrine Society</general><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope></search><sort><creationdate>20071201</creationdate><title>Dioxin Affects Glucose Transport via the Arylhydrocarbon Receptor Signal Cascade in Pluripotent Embryonic Carcinoma Cells</title><author>Tonack, Sarah ; Kind, Karen ; Thompson, Jeremy G ; Wobus, Anna M ; Fischer, Bernd ; Santos, Anne Navarrete</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c558t-3dfc8f8c8ba4bed87132b043de118588a9b5b97a1d501f0042c1e12eed9fad683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>Benzoflavones - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Biological Transport - drug effects</topic><topic>Blotting, Western</topic><topic>Cardiomyocytes</topic><topic>Cell activation</topic><topic>Cell differentiation</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell Line, Tumor</topic><topic>Cell Survival - drug effects</topic><topic>Cell viability</topic><topic>Cytochrome P-450 CYP1A1 - genetics</topic><topic>Cytochrome P-450 CYP1A1 - metabolism</topic><topic>Cytochrome P450</topic><topic>Cytochromes P450</topic><topic>Differentiation (biology)</topic><topic>Dioxins</topic><topic>Dioxins - pharmacology</topic><topic>Embryos</topic><topic>Fetuses</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression - drug effects</topic><topic>Glucose</topic><topic>Glucose - metabolism</topic><topic>Glucose transport</topic><topic>Glucose transporter</topic><topic>Glucose Transporter Type 1 - genetics</topic><topic>Glucose Transporter Type 1 - metabolism</topic><topic>Glucose Transporter Type 3 - genetics</topic><topic>Glucose Transporter Type 3 - metabolism</topic><topic>Heart</topic><topic>Intoxication</topic><topic>Isoforms</topic><topic>Metabolism</topic><topic>Mice</topic><topic>Myocytes, Cardiac - cytology</topic><topic>Myocytes, Cardiac - drug effects</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Myosin</topic><topic>Naphthoflavone</topic><topic>Pluripotency</topic><topic>Polychlorinated Dibenzodioxins - pharmacology</topic><topic>Receptors</topic><topic>Receptors, Aryl Hydrocarbon - antagonists &amp; inhibitors</topic><topic>Receptors, Aryl Hydrocarbon - physiology</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Signal Transduction - drug effects</topic><topic>TCDD</topic><topic>Toxicity</topic><topic>Transcription activation</topic><topic>Transcription, Genetic</topic><topic>Translocation</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tonack, Sarah</creatorcontrib><creatorcontrib>Kind, Karen</creatorcontrib><creatorcontrib>Thompson, Jeremy G</creatorcontrib><creatorcontrib>Wobus, Anna M</creatorcontrib><creatorcontrib>Fischer, Bernd</creatorcontrib><creatorcontrib>Santos, Anne Navarrete</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Endocrinology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tonack, Sarah</au><au>Kind, Karen</au><au>Thompson, Jeremy G</au><au>Wobus, Anna M</au><au>Fischer, Bernd</au><au>Santos, Anne Navarrete</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dioxin Affects Glucose Transport via the Arylhydrocarbon Receptor Signal Cascade in Pluripotent Embryonic Carcinoma Cells</atitle><jtitle>Endocrinology (Philadelphia)</jtitle><addtitle>Endocrinology</addtitle><date>2007-12-01</date><risdate>2007</risdate><volume>148</volume><issue>12</issue><spage>5902</spage><epage>5912</epage><pages>5902-5912</pages><issn>0013-7227</issn><eissn>1945-7170</eissn><coden>ENDOAO</coden><abstract>Intoxication by dioxins such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) leads, among other damages, to early embryo loss, fetal malformations, and cardiovascular toxicity. Apart from binding to the arylhydrocarbon receptor (AhR), the mechanism of TCDD-mediated embryo toxicity is still unclear. We investigated possible modes of a TCDD-mediated toxicity, particularly in glucose metabolism, in pluripotent P19 mouse embryonic carcinoma cells. Undifferentiated P19 cells were exposed to 1–100 nm TCDD and characterized for AhR signaling. For studying cell differentiation, P19 cells were exposed to 10 nm TCDD at stage of embryoid body formation, and analyzed on glucose metabolism and cardiac differentiation during the next 3 wk. TCDD treatment activated the AhR-signaling cascade within 1 h, confirmed by AhR translocation, induction of cytochrome P450 1A1 expression, and activation of the xenobiotic response element. Although cell viability and transcription of the cardiac marker protein α-myosin heavy chain were affected, TCDD did not inhibit the differentiation of P19 cells to pulsating cardiomyocytes. TCDD significantly down-regulated the expression levels of the glucose transporter (GLUT) isoforms 1 and 3. After 24-h TCDD treatment, GLUT1 was no longer localized in the plasma membrane of P19 cells. The impaired GLUT expression correlated with a lower glucose uptake in 5-d-old embryoid bodies. The TCDD effects were mediated by AhR, as shown by preculture with the AhR antagonist α-naphthoflavone. Our data demonstrate that an AhR-mediated disturbance in GLUT expression and insufficient glucose uptake may be major mechanisms in TCDD embryo toxicity.</abstract><cop>Bethesda, MD</cop><pub>Endocrine Society</pub><pmid>17872374</pmid><doi>10.1210/en.2007-0254</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0013-7227
ispartof Endocrinology (Philadelphia), 2007-12, Vol.148 (12), p.5902-5912
issn 0013-7227
1945-7170
language eng
recordid cdi_proquest_miscellaneous_19896613
source Oxford Journals Online
subjects Animals
Benzoflavones - pharmacology
Biological and medical sciences
Biological Transport - drug effects
Blotting, Western
Cardiomyocytes
Cell activation
Cell differentiation
Cell Differentiation - drug effects
Cell Line, Tumor
Cell Survival - drug effects
Cell viability
Cytochrome P-450 CYP1A1 - genetics
Cytochrome P-450 CYP1A1 - metabolism
Cytochrome P450
Cytochromes P450
Differentiation (biology)
Dioxins
Dioxins - pharmacology
Embryos
Fetuses
Fundamental and applied biological sciences. Psychology
Gene Expression - drug effects
Glucose
Glucose - metabolism
Glucose transport
Glucose transporter
Glucose Transporter Type 1 - genetics
Glucose Transporter Type 1 - metabolism
Glucose Transporter Type 3 - genetics
Glucose Transporter Type 3 - metabolism
Heart
Intoxication
Isoforms
Metabolism
Mice
Myocytes, Cardiac - cytology
Myocytes, Cardiac - drug effects
Myocytes, Cardiac - metabolism
Myosin
Naphthoflavone
Pluripotency
Polychlorinated Dibenzodioxins - pharmacology
Receptors
Receptors, Aryl Hydrocarbon - antagonists & inhibitors
Receptors, Aryl Hydrocarbon - physiology
Reverse Transcriptase Polymerase Chain Reaction
Signal Transduction - drug effects
TCDD
Toxicity
Transcription activation
Transcription, Genetic
Translocation
Vertebrates: endocrinology
title Dioxin Affects Glucose Transport via the Arylhydrocarbon Receptor Signal Cascade in Pluripotent Embryonic Carcinoma Cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T08%3A56%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dioxin%20Affects%20Glucose%20Transport%20via%20the%20Arylhydrocarbon%20Receptor%20Signal%20Cascade%20in%20Pluripotent%20Embryonic%20Carcinoma%20Cells&rft.jtitle=Endocrinology%20(Philadelphia)&rft.au=Tonack,%20Sarah&rft.date=2007-12-01&rft.volume=148&rft.issue=12&rft.spage=5902&rft.epage=5912&rft.pages=5902-5912&rft.issn=0013-7227&rft.eissn=1945-7170&rft.coden=ENDOAO&rft_id=info:doi/10.1210/en.2007-0254&rft_dat=%3Cproquest_cross%3E19896613%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c558t-3dfc8f8c8ba4bed87132b043de118588a9b5b97a1d501f0042c1e12eed9fad683%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3130585760&rft_id=info:pmid/17872374&rft_oup_id=10.1210/en.2007-0254&rfr_iscdi=true